Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups.
Bolli N, Biancon G, Moarii M, Gimondi S, Li Y, de Philippis C, Maura F, Sathiaseelan V, Tai YT, Mudie L, O'Meara S, Raine K, Teague JW, Butler AP, Carniti C, Gerstung M, Bagratuni T, Kastritis E, Dimopoulos M, Corradini P, Anderson KC, Moreau P, Minvielle S, Campbell PJ, Papaemmanuil E, Avet-Loiseau H, Munshi NC. Bolli N, et al. Among authors: de philippis c. Leukemia. 2018 Dec;32(12):2604-2616. doi: 10.1038/s41375-018-0037-9. Epub 2018 May 22. Leukemia. 2018. PMID: 29789651 Free PMC article.
Persistence of KIRneg NK cells after haploidentical hematopoietic stem cell transplantation protects from human cytomegalovirus infection/reactivation.
Di Vito C, Coianiz N, Calvi M, Terzoli S, Zaghi E, Puccio S, Frigo A, Mariotti J, De Philippis C, Mannina D, Sarina B, Mineri R, Le-Trilling VTK, Trilling M, Castagna L, Bramanti S, Santoro A, Mavilio D. Di Vito C, et al. Among authors: de philippis c. Front Immunol. 2024 Jan 10;14:1266051. doi: 10.3389/fimmu.2023.1266051. eCollection 2023. Front Immunol. 2024. PMID: 38268918 Free PMC article.
Out of specification Tisagenlecleucel is associated with outcomes comparable to standard of care product in relapsed or refractory diffuse large B-cell lymphoma.
De Philippis C, Zucchinetti C, Mannina D, Krampera M, Zinzani PL, Chiappella A, di Rocco A, Orcioulo E, Tisi MC, Pistolese F, Giordano L, Santoro A, Bramanti S. De Philippis C, et al. Bone Marrow Transplant. 2024 Apr;59(4):569-571. doi: 10.1038/s41409-024-02205-6. Epub 2024 Jan 25. Bone Marrow Transplant. 2024. PMID: 38272998 No abstract available.
Deep learning and atlas-based models to streamline the segmentation workflow of total marrow and lymphoid irradiation.
Dei D, Lambri N, Crespi L, Brioso RC, Loiacono D, Clerici E, Bellu L, De Philippis C, Navarria P, Bramanti S, Carlo-Stella C, Rusconi R, Reggiori G, Tomatis S, Scorsetti M, Mancosu P. Dei D, et al. Among authors: de philippis c. Radiol Med. 2024 Mar;129(3):515-523. doi: 10.1007/s11547-024-01760-8. Epub 2024 Feb 2. Radiol Med. 2024. PMID: 38308062
Impact of daratumumab on collection and engraftment in multiple myeloma patients undergoing hematopoietic stem cell mobilization with G-CSF plus on-demand plerixafor.
Bertuglia G, Garibaldi B, Casson A, Sarina B, Gay F, Mercadante S, Mariotti J, D'agostino M, Taurino D, Oliva S, Larocca A, Mannina D, De Philippis C, Benevolo G, Francisci T, Lorenzi M, Bruno B, Santoro A, Bringhen S, Mina R, Bramanti S. Bertuglia G, et al. Among authors: de philippis c. Bone Marrow Transplant. 2024 Oct 4. doi: 10.1038/s41409-024-02432-x. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 39367227 No abstract available.
Deep learning-based optimization of field geometry for total marrow irradiation delivered with volumetric modulated arc therapy.
Lambri N, Longari G, Loiacono D, Brioso RC, Crespi L, Galdieri C, Lobefalo F, Reggiori G, Rusconi R, Tomatis S, Bellu L, Bramanti S, Clerici E, De Philippis C, Dei D, Navarria P, Carlo-Stella C, Franzese C, Scorsetti M, Mancosu P. Lambri N, et al. Among authors: de philippis c. Med Phys. 2024 Jun;51(6):4402-4412. doi: 10.1002/mp.17089. Epub 2024 Apr 18. Med Phys. 2024. PMID: 38634859
Autoimmune diseases during treatment with immunomodulatory drugs in multiple myeloma: selective occurrence after lenalidomide.
Montefusco V, Galli M, Spina F, Stefanoni P, Mussetti A, Perrone G, De Philippis C, Dalto S, Maura F, Bonini C, Rezzonico F, Pennisi M, Roncari L, Soldarini M, Dodero A, Farina L, Cocito F, Caprioli C, Corradini P. Montefusco V, et al. Among authors: de philippis c. Leuk Lymphoma. 2014 Sep;55(9):2032-7. doi: 10.3109/10428194.2014.914203. Epub 2014 Jun 5. Leuk Lymphoma. 2014. PMID: 24730540
Haploidentical Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Post-Transplantation Cyclophosphamide Graft-versus-Host Disease Prophylaxis.
Castagna L, Mussetti A, Devillier R, Dominietto A, Marcatti M, Milone G, Maura F, de Philippis C, Bruno B, Furst S, Blaise D, Corradini P, Montefusco V. Castagna L, et al. Among authors: de philippis c. Biol Blood Marrow Transplant. 2017 Sep;23(9):1549-1554. doi: 10.1016/j.bbmt.2017.05.006. Epub 2017 May 10. Biol Blood Marrow Transplant. 2017. PMID: 28499937 Free article.
65 results